II National Conference on Biosimilars – Biosimilars: evidence and efficiency

Events

February 21th 2018Events
After the success of the first Annual Conference on Biosimilars, on February 21, 2018, its second edition entitled "Biosimilars: Evidence and Efficiency" was held in Madrid. The event was presided over by the General Secretary for Health and Consumption and the General Directorate for the Quality of Medicines and Health Products and managed to bring together multiple professionals from the sector around its three thematic tables.

PROGRAM VIDEO PHOTOS

PRESENTATIONS

The clinical management of biosimilars
Dr. Alejandro Balsa
Rheumatology Service. La Paz University Hospital, Madrid

OPEN

Efficiency: management of biosimilars in the hospital setting
Candela Rodriguez Street
Managing director. Catalan Health Institute. CEO. Catalan Institute of Oncology

OPEN

Efficiency: Management of biosimilars in the hospital setting. Hospital pharmacy

Dr. Miguel Angel Calleja
HU Virgin Macarena. SEFH President

OPEN

Health Economics and Biosimilars

Felix Wolf
Emeritus Professor Carlos III University of Madrid. Department of Economy and FUNCAS

OPEN

Regulatory aspects of biosimilars

Antonio Blazquez Perez
Deputy Head of the Department of Medicines for Human Use of the Spanish Agency for Medicines and Health Products, AEMPS

OPEN

Development and Manufacturing of Biosimilars - Monoclonal Antibodies

Francis Olivera
Operations Manager at Mabxience

OPEN

Utilizzo dei pharmaci biosimilari ed exempli virtuosi

Dr. Ugo Plot
UOD Drug and Device Policy. Directorate General Greetings. SSR Campania Region

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE